J Clin Neurol.  2016 Oct;12(4):502-504. 10.3988/jcn.2016.12.4.502.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient with Systemic Lupus Erythematosus

• Wu YY
• Feng Y
• Huang Y
• Zhang JW

• KMID: 2385117
• DOI: http://doi.org/10.3988/jcn.2016.12.4.502

Abstract

No abstract available.

MeSH Terms

Anti-N-Methyl-D-Aspartate Receptor Encephalitis*
Humans
Lupus Erythematosus, Systemic*

Figure

• 

  Fig. 1 A: T2 weighted images of the patient. It showed mild hyperintensity in right temporal and parietal lobe. B: T1 weighted images of the patient. It showed mild hyperintensity in right temporal and parietal lobe. C: Fluid attenuated inversion recovery sequences images of the patient. It showed hyperintensity in right temporal and parietal lobe. D: Diffusion-weighted image lesion of the patient. It showed hyperintensity in right temporal and parietal lobe. E: ADC lesion of the patient. It showed hyperintensity in right temporal and parietal lobe. F: MRI enhancement of the patient. It showed a ring-shaped reinforcement.

Reference

1. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61:25–36.

2. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7:1091–1098.

3. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10:63–74.

4. Steup-Beekman GM, Zirkzee EJ, Cohen D, Gahrmann BM, Emmer BJ, Steens SC, et al. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause. Ann Rheum Dis. 2013; 72:Suppl 2. ii76–ii79.

5. Husebye ES, Sthoeger ZM, Dayan M, Zinger H, Elbirt D, Levite M, et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis. 2005; 64:1210–1213.

6. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol. 2005; 12:392–398.

7. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001; 7:1189–1193.

8. Mackay G, Ahmad K, Stone J, Sudlow C, Summers D, Knight R, et al. NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease. J Neurol. 2012; 259:1979–1981.

9. Ogawa E, Nagai T, Sakuma Y, Arinuma Y, Hirohata S. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. Mod Rheumatol. 2016; 26:377–383.

10. Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL, et al. Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry. 2015; 86:708–713.